Treatment of classical Kaposi's sarcoma with intralesional injections of cidofovir: Report of a case
β Scribed by Simonart, Thierry; Noel, Jean-Christophe; De Dobbeleer, Gilbert; Parent, Dominique; Van Vooren, Jean-Paul; De Clercq, Erik; Snoeck, Robert
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 135 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
The effect of intralesional injections of cidofovir, a nucleotide analog with potent in vitro activity against human herpesvirus 8 (HHV-8), was studied in vivo in an HIV-negative patient with classical Kaposi's sarcoma (KS). After five weekly injections of the drug, no clinical, histological, immunohistological, or virological changes could be detected in comparison with salineinjected lesions. These findings suggest that, once the KS tumor has developed, active viral replication is no longer involved in the pathogenesis of the disease. Alternative hypotheses are that HHV-8 replication in blood-borne cells may foster growth of spindle cells in the skin, or that blocking HHV-8 may not affect existing lesions but may prevent new lesions from developing.
π SIMILAR VOLUMES
Respiratory papillomatosis is a rare and often severe disease, usually localized in the larynx. It may cause respiratory distress and even life-threatening obstruction of the airways. Treatment is generally based on the evaporation of the lesions with a CO2 laser, but microsurgery, cytotoxic and/or
Autoimmune thrombocytopenic purpura associated with Kaposi's sarcoma in a 42year-old male from the south of Saudi Arabia is reported. This association has not previously been reported in the medical literature. The occurrence of Kaposi's sarcoma in renal transplant recipients and in those suffering
An 8-year-old Taiwanese girl presenting with generalized petechial hemorrhages, severe thrombocytopenia and lymphadenopathy was found to have primary Kaposi's sarcoma of lymph node without cutaneous involvement. This patient is a first-documented case of lymphadenopathic type of Kaposi's sarcoma in